Daniel D. Gretler
Corporate Officer/Principal presso Stanford University
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| John Kryzwicki | M | - |
Stanford University
| 7 anni |
| Pin Pin Tea-Mankorn | F | - |
Stanford University
| 10 anni |
| John J. Schembri | M | 62 |
COR Therapeutics, Inc.
 COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | 4 anni |
| Nathan Nolop | M | - |
Stanford University
| 11 anni |
| Jonathan Hsu | M | - |
Stanford University
| 5 anni |
| Ben Daniel | M | - |
Stanford University
| 1 anni |
| Seth Silverman | M | - |
Stanford University
| 5 anni |
| Clancey Stahr | M | - |
Stanford University
| 4 anni |
| Christopher E Olin | M | - |
Stanford University
| 7 anni |
| Adam Klotz | M | - |
Stanford University
| 10 anni |
| Joel Dudley | M | - |
Stanford University
| 4 anni |
| Haomiao Huang | M | - |
Stanford University
| 7 anni |
| Enrique Zambrano | M | - |
Stanford University
| 7 anni |
| Sahil Bloom | M | - |
Stanford University
| 4 anni |
| Geoffrey Woo | M | - |
Stanford University
| 4 anni |
| Iveshu Bhatia | M | - |
Stanford University
| 1 anni |
| Jung-il Choi | M | - |
Stanford University
| 6 anni |
| Chase Beeler | M | - |
Stanford University
| 5 anni |
| John Melas-Kyriazi | M | - |
Stanford University
| 4 anni |
| Elaine Zelby | F | - |
Stanford University
| 5 anni |
| Wesley Lim | M | - |
Stanford University
| 4 anni |
| Artem Barsukov | M | - |
Stanford University
| 3 anni |
| Christina Ho | F | - |
Stanford University
| 5 anni |
| Vic Miller | M | - |
Stanford University
| 4 anni |
| Petr Johanes | M | - |
Stanford University
| 12 anni |
| Guillaume Horel | M | - |
Stanford University
| 4 anni |
| Andreas Eckner | M | - |
Stanford University
| 4 anni |
| David McColl | M | - |
Stanford University
| 6 anni |
| Forrest White | M | - |
Stanford University
| 5 anni |
| Argyrios Zymnis | M | - |
Stanford University
| 5 anni |
| Karen Martell | F | - |
Stanford University
| 4 anni |
| Leeor Mushin | M | - |
Stanford University
| 2 anni |
| Ibrahim Almojel | M | - |
Stanford University
| 6 anni |
| Edward Segal | M | - |
Stanford University
| 4 anni |
| Artem Trotsyuk | M | - |
Stanford University
| 4 anni |
| Haithem Turki | M | - |
Stanford University
| 10 anni |
| Alisha Adam | F | - |
Stanford University
| 5 anni |
| Kristen Wong | F | - |
Stanford University
| 4 anni |
| Mada Seghete | F | - |
Stanford University
| 8 anni |
| Djalil Reghis | M | - |
Stanford University
| 2 anni |
| Lisa Hersch | F | - |
Stanford University
| 2 anni |
| Mike Rothenberg | M | - |
Stanford University
| 5 anni |
| Gülin Yilmaz | F | - |
Stanford University
| 4 anni |
| Jon Cheek | M | - |
Stanford University
| 7 anni |
| Stephen M. McConnell | M | - |
The University of Chicago
| 1 anni |
| Jenny P. Chen | F | - |
Stanford University
| 6 anni |
| R. Lee Douglas | M | 72 |
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | 10 anni |
| Rapp Alyssa | F | 45 |
Stanford University
| 2 anni |
| Hugh Browne | M | - |
Stanford University
| 2 anni |
| Manu Lakkur | M | - |
Stanford University
| 5 anni |
| James Topper | M | 62 |
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | 4 anni |
| Lou Fernandes | M | - |
Stanford University
| 2 anni |
| Martin Casado | M | - |
Stanford University
| 6 anni |
| Nathan Evans | M | - |
Stanford University
| 6 anni |
| Sampath Jinadasa | M | - |
Stanford University
| 5 anni |
| Michael Paulus | M | - |
Stanford University
| 5 anni |
| James P. McGillicuddy | M | - |
Stanford University
| 5 anni |
| Nafis Jamal | M | - |
Stanford University
| 7 anni |
| Charles Homcy | M | 75 |
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | 14 anni |
| Peter Moran | M | - |
Stanford University
| 4 anni |
| Renata Streit Quintini | F | - |
Stanford University
| 4 anni |
| Rahul Samat | M | - |
Stanford University
| 2 anni |
| Rhett Neuenschwander | M | - |
Stanford University
| 2 anni |
| Rafal Styczen | M | 53 |
Stanford University
| 1 anni |
| Martin Sumner | M | 50 |
Stanford University
| 2 anni |
| Jessica Verrilli | F | - |
Stanford University
| 4 anni |
| David H. Beisel | M | - |
Stanford University
| 2 anni |
| Kirk Wolfe | M | - |
Stanford University
| 2 anni |
| Gracie Zaro | F | - |
Stanford University
| 4 anni |
| Stephen Westwell | M | 66 |
Stanford University
| 1 anni |
| Scott Bromley | M | - |
Stanford University
| 2 anni |
| Varun Bindra | M | - |
Stanford University
| 3 anni |
| Anthony J. Limberis | M | - |
Stanford University
| 2 anni |
| David S. Glynn | M | - |
Stanford University
| 2 anni |
| Benjamin Kim | M | - |
Stanford University
| 6 anni |
| Meredith Nelson | F | - |
Stanford University
| 4 anni |
| Zachary Witlin | M | - |
Stanford University
| 1 anni |
| Amr Awadallah | M | - |
Stanford University
| 3 anni |
| Maxwell S. Burke | M | - |
Stanford University
| 2 anni |
| Darren Minton | M | 41 |
Stanford University
| 4 anni |
| Jennifer Place | F | - |
Stanford University
| 4 anni |
| Daniel Goldberger | M | 65 |
Stanford University
| 1 anni |
| Lauren Gross | F | - |
Stanford University
| 4 anni |
| Thomas P. Chung | M | - |
Stanford University
| 4 anni |
| Paul Strachman | M | - |
Stanford University
| 2 anni |
| Jason Hsiao Chen | M | - |
Stanford University
| 1 anni |
| Kathryn Hume | M | - |
Stanford University
| 5 anni |
| Jake Jolis | M | - |
Stanford University
| 2 anni |
| Reshma Karipineni | F | - |
Stanford University
| 2 anni |
| Naomi Pilosof Ionita | F | - |
Stanford University
| 2 anni |
| Nicholas Hsu | M | - |
Stanford University
| 4 anni |
| Parag Agrawal | M | 40 |
Stanford University
| 3 anni |
| Ethan Bing | M | - |
Stanford University
| 2 anni |
| Susan Li | F | 38 |
Stanford University
| 4 anni |
| Betty Vo | F | - |
Stanford University
| 4 anni |
| Lee Ward | M | - |
Stanford University
| 5 anni |
| Carolyn Janiak Earthy | F | - |
Stanford University
| 3 anni |
| Enrique Garcia | M | - |
Stanford University
| 4 anni |
| Yuval Grill | M | - |
Stanford University
| 2 anni |
| Eric Kroll | M | - |
Stanford University
| 2 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 100 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Daniel D. Gretler
- Contatti personali
